Avinger (AVGR) Reports Q1 Loss of $1.06/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. ALHC
3. SPCX
4. CVS
5. T
6. UNH
7. AXP
8. VZ
9. PEP
10. RTX

Go back to Avinger (AVGR) Reports Q1 Loss of $1.06/Share

Avinger, Inc. Announces Second Quarter 2016 Results

August 1, 2016 4:01 PM EDT

REDWOOD CITY, Calif., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR) (the Company), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the second quarter ended June 30, 2016.

Second Quarter Highlights

Revenue of $4.7 million, a 54% increase compared to the second quarter of 2015Added 19 lumivascular accounts, the most in a single quarter, expanding the installed base of the Company's lumivascular platform to 126 accounts

While our installed base of lumivascular accounts grew significantly in the second quarter, we experienced lower than... More